Hamid Khoja
Fortune : 3 553 $ au 31/05/2026
Fortune : 3 553 $ au 31/05/2026
Hamid Khoja is currently Chief Scientific Officer at FibroBiologics, Inc. since 2021.
Formerly, worked as Principal Scientist at Covaris LLC from 2009 to 2021, and as Scientist at Chiron Corp.
and Eli Lilly & Co. Education includes a doctorate from Boston University and an undergraduate degree from the University of Southern California.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
FIBROBIOLOGICS, INC. 0,06 % | 04/05/2026 | 3 063 ( 0,06 % ) | 3 553 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| FIBROBIOLOGICS, INC. | Directeur Technique/Scientifique/R&D | 01/08/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
Covaris LLC
Covaris LLC Medical SpecialtiesHealth Technology Develops, manufactures and markets instruments, consumables & reagents | Corporate Officer/Principal | 01/08/2021 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Directeur Technique/Scientifique/R&D | - |
| ELI LILLY AND COMPANY | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Covaris LLC
Covaris LLC Medical SpecialtiesHealth Technology Develops, manufactures and markets instruments, consumables & reagents | Health Technology |
FibroBiologics, Inc.
FibroBiologics, Inc. BiotechnologyHealth Technology Develops and commercializes fibroblast-based cell therapies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national